Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03723707 · ClinicalTrials.gov registry record · NA
Enhanced Quality in Primary Care for Elders With Diabetes and Dementia
A NA study of Diabetes and Alzheimer Disease, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 355
- Enrollment target
- 1
- Study location
NCT03723707: Completed NA study of Diabetes and Alzheimer Disease, sponsored by NYU Langone Health.
NCT03723707 is a NA study of Diabetes and Alzheimer Disease that has completed, run by NYU Langone Health. The registered enrollment target is 355 participants, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03723707, a NA study of Diabetes and Alzheimer Disease, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 355 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop and test a care quality improvement intervention featuring use of consensus decisional guidance for the medical management of diabetes (DM) in patients with Alzheimer's disease and related dementia (ADRD) in primary care, provider (PCP) workflow enhancements supported by a panel manager(PM) for workflow support, electronic health record (EHR) decision support and feedback, and PCP collaborative learning.
Primary Outcome
Percentage of patients with normal HbA1c (\>=7 and \<=8.5) at the end of the trial after completing the 24-month Follow-up and who had reported values in their electronic health record within 6 months of study completion.
Conditions Studied
Interventions
- BEHAVIORAL Control (CON)
- BEHAVIORAL EQUIPED-ADRD Intervention
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 355 participants |
| Start Date | 2018-12-03 |
| Est. Completion | 2022-10-20 |
| Phase | NA |
What the finished NCT03723707 record still lists
NCT03723707 is an interventional study that assigns participants to a tested intervention. The registered 355 participants enrollment target is mid-sized for trials with a published cap, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Control (CON) is the first listed.
NCT03723707 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03723707 about?
NCT03723707 is a clinical study titled "Enhanced Quality in Primary Care for Elders With Diabetes and Dementia". The purpose of this study is to develop and test a care quality improvement intervention featuring use of consensus decisional guidance for the medical management of diabetes (DM) in patients with Alzheimer's disease and related dementia (ADRD) in primary care, provider (PCP) workflow enhancements s...
What is the current status of trial NCT03723707?
This trial is currently completed. It is a NA study. The enrollment target is 355 participants. The study started on 2018-12-03. Estimated completion is 2022-10-20.
What conditions does trial NCT03723707 study?
This clinical trial studies the following conditions: Diabetes, Alzheimer Disease, Dementia.
What interventions are being tested in trial NCT03723707?
The interventions under investigation include: Control (CON) (BEHAVIORAL), EQUIPED-ADRD Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03723707?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03723707 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03723707's enrollment target sits among peer trials
355 100th of 338 higher than 239 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07133308 · 355 participants · Phase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- NCT07193511 · 355 participants · Phase 1
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
- NCT06077838 · 356 participants · NA
RELAXaHEAD for Headache Patients (Phase III)
- NCT06293469 · 356 participants · NA
Accelerated Flap Coverage in Severe Lower Extremity Trauma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI